-
Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus
Ellison, T. S., Cappa, S. F., Garrett, D., Georges, J., Iwatsubo, T., Kramer, J. H., Lehmann, M., Lyketsos, C., Maier, A. B., Merrilees, J., Morris, J. C., Naismith, S. L., Nobili, F., Pahor, M., Pond, D., Robinson, L., Soysal, P., Vandenbulcke, M., Weber, C. J., Visser, P. J., & 2 others , 1 Jun 2023, In: Alzheimer's and Dementia. 19, 6, p. 2707-2729 23 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Alzheimer’s Disease Genetics Consortium, 1 Dec 2022, In: Scientific reports. 12, 1, 6117.Research output: Contribution to journal › Article › Academic › peer-review
-
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
Advancing Research and Treatment for Frontotemporal Lobar Degeneration investigators, 1 Sept 2021, In: Lancet neurology. 20, 9, p. 739-752 14 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications